2,513
Views
1
CrossRef citations to date
0
Altmetric
Original Articles

Patient-reported pain after surgical removal of leukoplakia – an observational 1-year follow-up study

ORCID Icon, ORCID Icon, ORCID Icon, , ORCID Icon, , , , , ORCID Icon & ORCID Icon show all
Pages 383-389 | Received 20 Jul 2020, Accepted 21 Dec 2020, Published online: 21 Jan 2021

References

  • Kramer IR, Lucas RB, Pindborg JJ, et al. Definition of leukoplakia and related lesions: an aid to studies on oral precancer. Oral Surg Oral Med Oral Pathol. 1978;46(4):518–539.
  • van der Waal I, Axell T. Oral leukoplakia: a proposal for uniform reporting. Oral Oncol. 2002;38(6):521–526.
  • van der Waal I. Potentially malignant disorders of the oral and oropharyngeal mucosa; terminology, classification and present concepts of management. Oral Oncol. 2009;45(4–5):317–323.
  • Lodi G, Porter S. Management of potentially malignant disorders: evidence and critique. J Oral Pathol Med. 2008;37(2):63–69.
  • Warnakulasuriya S, Ariyawardana A. Malignant transformation of oral leukoplakia: a systematic review of observational studies. J Oral Pathol Med. 2016;45(3):155–166.
  • Banoczy J, Gintner Z, Dombi C. Tobacco use and oral leukoplakia. J Dent Educ. 2001;65(4):322–327.
  • Sundberg J, Öhman J, Korytowska M, et al. High-risk human papillomavirus in patients with oral leukoplakia and oral squamous cell carcinoma – a multi-centre study in Sweden, Brazil and Romania. Oral Dis. 2020;1–10.
  • van der Waal I. Oral potentially malignant disorders: is malignant transformation predictable and preventable? Med Oral Patol Oral Cir Bucal. 2014;19(4):e386–e390.
  • Thomson PJ, Wylie J. Interventional laser surgery: an effective surgical and diagnostic tool in oral precancer management. Int J Oral Maxillofac Surg. 2002;31(2):145–153.
  • Holmstrup P, Dabelsteen E. Oral leukoplakia—to treat or not to treat. Oral Dis. 2016;22(6):494–497.
  • Holmstrup P, Vedtofte P, Reibel J, et al. Long-term treatment outcome of oral premalignant lesions. Oral Oncol. 2006;42(5):461–474.
  • Pandey M, Thomas G, Somanathan T, et al. Evaluation of surgical excision of non-homogeneous oral leukoplakia in a screening intervention trial, Kerala, India. Oral Oncol. 2001;37(1):103–109.
  • Brouns E, Baart JA, Karagozoglu KH, et al. Malignant transformation of oral leukoplakia in a well-defined cohort of 144 patients. Oral Dis. 2014;20(3):e19–e24.
  • Sundberg J, Korytowska M, Holmberg E, et al. Recurrence rates after surgical removal of oral leukoplakia—a prospective longitudinal multi-centre study. PLoS One. 2019;14(12):e0225682.
  • Lodi G, Franchini R, Warnakulasuriya S, et al. Interventions for treating oral leukoplakia to prevent oral cancer. Cochrane Database Syst Rev. 2016;7:CD001829.
  • Karbach J, Al-Nawas B, Moergel M, et al. Oral health-related quality of life of patients with oral lichen planus, oral leukoplakia, or oral squamous cell carcinoma. J Oral Maxillofac Surg. 2014;72(8):1517–1522.
  • Liu LJ, Xiao W, He QB, et al. Generic and oral quality of life is affected by oral mucosal diseases. BMC Oral Health. 2012;12(1):2.
  • Tadakamadla J, Kumar S, Lalloo R, et al. Impact of oral potentially malignant disorders on quality of life. J Oral Pathol Med. 2018;47(1):60–65.
  • Lopez-Jornet P, Camacho-Alonso F. Comparison of pain and swelling after removal of oral leukoplakia with CO2 laser and cold knife: a randomized clinical trial. Med Oral Patol Oral Cir Bucal. 2013;18(1):e38–e44.
  • Lin HY, Chen SC, Peng HL, et al. Unmet information needs and clinical characteristics in patients with precancerous oral lesions. Eur J Cancer Care (Engl). 2015;24(6):911–919.
  • Flaitz CM, Carlin N. Living in limbo: ethics and experience in a conversation about persistent oral lesions. Tex Dent J. 2013;130(8):692–701.
  • Grant PS. Analgesia delivery in the ED. Am J Emerg Med. 2006;24(7):806–809.
  • Williamson A, Hoggart B. Pain: a review of three commonly used pain rating scales. J Clin Nurs. 2005;14(7):798–804.
  • El-Naggar AK, Grandis JR, Takata T, et al. WHO classification of head and neck tumours. WHO classification of tumours. Vol. 9. 4th ed. International Agency for Research on Cancer; 2017.
  • Hawker GA, Mian S, Kendzerska T, et al. Measures of adult pain: Visual Analog Scale for Pain (VAS Pain), Numeric Rating Scale for Pain (NRS Pain), McGill Pain Questionnaire (MPQ), Short-Form McGill Pain Questionnaire (SF-MPQ), Chronic Pain Grade Scale (CPGS), Short Form-36 Bodily Pain Scale (SF-36 BPS), and Measure of Intermittent and Constant Osteoarthritis Pain (ICOAP). Arthritis Care Res (Hoboken). 2011;63(Suppl. 11):S240–S252.
  • Kelly AM. The minimum clinically significant difference in visual analogue scale pain score does not differ with severity of pain. Emerg Med J. 2001;18(3):205–207.
  • Balasundaram I, Payne KFB, Al-Hadad I, et al. Is there any benefit in surgery for potentially malignant disorders of the oral cavity? J Oral Pathol Med. 2014;43(4):239–244.
  • Min Ang X, Chi Khang Au P, Kwok K, et al. Quality of life in patients with oral leukoplakia. J Oral Pathol Med. 2019;48(7):574–580.
  • Sirintawat N, Sawang K, Chaiyasamut T, et al. Pain measurement in oral and maxillofacial surgery. J Dent Anesth Pain Med. 2017;17(4):253–263.
  • Saibene AM, Rosso C, Castellarin P, et al. Managing benign and malignant oral lesions with carbon dioxide laser: indications, techniques, and outcomes for outpatient surgery. Surg J. 2019;5(3):e69–e75.
  • Asnaashari M, Zadsirjan S. Application of laser in oral surgery. J Lasers Med Sci. 2014;5(3):97–107.